Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials.
The classification of Tissue Engineering includes Synthetic Materials, Biologically Derived Materials and other. And the revenue proportion of Biologically Derived Materials in 2016 is about 54%, and the proportion of Synthetic Materials is 16%.
Tissue Engineering is widely used in Orthopedics Musculoskeletal &Spine, Neurology, Cardiology & Vascular, Skin & Integumentary and other field.
North America region is the largest supplier of Tissue Engineering, with a production revenue market share nearly 54% in 2016. Europe is the second largest supplier of Tissue Engineering, enjoying production revenue market share nearly 31% in 2016.
North America is the largest consumption place, with a consumption market share nearly 43% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Allergan, Integra Lifesciences, C. R. Bard, and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Tissue Engineering market was valued at US$ 20030 million in 2019 and is expected to reach US$ 67340 million by the end of 2026, growing at a CAGR of 18.7% during 2021-2026.
This report focuses on Tissue Engineering volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tissue Engineering market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Tissue Engineering Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Synthetic Materials
Biologically Derived Materials
Segment by Application
Neurology
Cardiology & Vascular
Skin & Integumentary
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Integra Lifesciences
C. R. Bard
Zimmer Biomet
Organogenesis
Osiris Therapeutics
Cryolife
ACell
Biocomposites
DSM
Episkin
J-TEC
Athersys
Biotime
B. Braun
International Stem Cell
Bio Tissue Technologies
The classification of Tissue Engineering includes Synthetic Materials, Biologically Derived Materials and other. And the revenue proportion of Biologically Derived Materials in 2016 is about 54%, and the proportion of Synthetic Materials is 16%.
Tissue Engineering is widely used in Orthopedics Musculoskeletal &Spine, Neurology, Cardiology & Vascular, Skin & Integumentary and other field.
North America region is the largest supplier of Tissue Engineering, with a production revenue market share nearly 54% in 2016. Europe is the second largest supplier of Tissue Engineering, enjoying production revenue market share nearly 31% in 2016.
North America is the largest consumption place, with a consumption market share nearly 43% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Allergan, Integra Lifesciences, C. R. Bard, and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Tissue Engineering market was valued at US$ 20030 million in 2019 and is expected to reach US$ 67340 million by the end of 2026, growing at a CAGR of 18.7% during 2021-2026.
This report focuses on Tissue Engineering volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Tissue Engineering market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Tissue Engineering Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Synthetic Materials
Biologically Derived Materials
Segment by Application
Neurology
Cardiology & Vascular
Skin & Integumentary
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Integra Lifesciences
C. R. Bard
Zimmer Biomet
Organogenesis
Osiris Therapeutics
Cryolife
ACell
Biocomposites
DSM
Episkin
J-TEC
Athersys
Biotime
B. Braun
International Stem Cell
Bio Tissue Technologies
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
